National Institute of Neurological Disorders and Stroke
Overview
National Institute of Neurological Disorders and Stroke is a United States federal government agency that seeks fundamental knowledge about the brain and nervous system and uses that knowledge to reduce the burden of neurological disease by supporting and performing basic, translational, and clinical research.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| MicroTransponder | Feb 2010 | Grant | Co-investor |
| Quiver Bioscience | May 2026 | Grant | Co-investor |
| FYR Diagnostics | Oct 2019 | Grant | Lead |
| ZZ Biotech | May 2022 | Grant | Lead |
| Tellus Therapeutics | Dec 2020 | Grant | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is National Institute of Neurological Disorders and Stroke based?
National Institute of Neurological Disorders and Stroke is headquartered in Bethesda, Maryland, United States.
When was National Institute of Neurological Disorders and Stroke founded?
National Institute of Neurological Disorders and Stroke was founded in 1950.
How many portfolio companies does National Institute of Neurological Disorders and Stroke have?
National Institute of Neurological Disorders and Stroke has 43 portfolio companies in Caplight's dataset.
What are some companies in National Institute of Neurological Disorders and Stroke's portfolio?
Portfolio companies visible on Caplight include MicroTransponder, Quiver Bioscience, FYR Diagnostics, ZZ Biotech, Tellus Therapeutics.
What was National Institute of Neurological Disorders and Stroke's most recent investment shown here?
National Institute of Neurological Disorders and Stroke's most recent investment in this portfolio sample was in Quiver Bioscience in 2026.
What sectors does National Institute of Neurological Disorders and Stroke focus on?
National Institute of Neurological Disorders and Stroke focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, Frontier & Industrial Tech, AI, Data & Cloud Infrastructure, Enterprise Software, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does National Institute of Neurological Disorders and Stroke focus on?
National Institute of Neurological Disorders and Stroke typically invests at the MultiStage stage.